Oxygen is a colorless, non-metallic gas that is highly reactive in nature. Oxygen forms oxides with many compounds and other elements. The oxygen is used in various applications, such as steel mills to oxidize unwanted impurities in steel. Oxygen is also used in the food industry, medical oxygen for respiration, and oxy-acetylene torches. The main product types of oxygen are medical oxygen, industrial oxygen, and other product types. Medical oxygen is high purity oxygen that has been used for medical treatments and has been developed for use in the human body. Medical oxygen cylinders contain only high purity oxygen gas; no other gases are permitted in the cylinder to avoid contamination. The various applications are cosmetics, pharmaceuticals, automobiles, mining, and mineral processing applications. The various applications are the metallurgical industry, chemical industry, health care industry, and other applications. The oxygen market research report is one of a series of new reports from The Business Research Company that provides oxygen market statistics, including oxygen industry global market size, regional shares, competitors with an oxygen market share, detailed oxygen market segments, market trends and opportunities, and any further data you may need to thrive in the oxygen industry. This oxygen market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global oxygen market size will grow from $34.83 billion in 2022 to $39.28 billion in 2023 at a compound annual growth rate (CAGR) of 12.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global oxygen market size is expected to grow from $62.36 billion in 2027 at a CAGR of 12.2%. The increasing prevalence of various diseases related to breathing problems has contributed to the global oxygen market’s growth by increasing the use of oxygen for medical purposes. Diseases such as Chronic Obstructive Pulmonary Disease (COPD) are more prevalent in the geriatric population. COPD is a type of obstructive lung disease that results in long-term breathing problems. COPD requires the use of an oxygen concentrator, which is a device that improves the level of oxygen in the blood of patients and addresses their breathing problems. According to the United Nations (UN), in 2020, there were an estimated 727 million people aged 65 years or over worldwide, and that number is expected to reach 1.5 billion by 2050. Thus, the increased number of such cases has spurred the demand for portable oxygen concentrators, which is therefore driving the oxygen market’s growth. Lack of safety measures adopted while handling oxygen in industries such as manufacturing, mining, etc. limits the growth of the oxygen market. Though oxygen is not flammable itself, it can cause other materials to catch fire. Excessive contact with liquid oxygen can cause severe skin and eye irritation and burns, as well as frostbite. Further, any leak in oxygen containers if kept in a poorly ventilated room can cause severe damage to life and property. For example, in June 2021, an oxygen tank explosion killed a man in Springfield, Missouri, the USA. Therefore, a lack of safety measures while handling oxygen negatively affects the oxygen market. Companies involved in the market are developing innovative ways to utilize oxygen in various industries such as medical, chemical, etc. The rising need among patients across healthcare services acts as a driving force for companies to find new innovative ways to improve oxygen delivery. In order to improve the oxygen delivery and to monitor the oxygen dosage of patients in respiratory care facilities, Camcon Medical introduced Binary Actuation Technology (BAT). BAT is an innovative solution that aids in providing accurate dosage and reduces wastage by providing cost-effective solutions to patients who require oxygen therapy. It is through such innovative methods that entities involved in the oxygen market are able to improve the economic benefit of the products. In August 2021, Linde, an Ireland-based chemical company, acquired HPS Gases for the amount of INR 27.5 crores. This acquisition of HPS Gases will strengthen its position and help it grow as an organization. HPS Gases is an India-based manufacturer of industrial gases. Major players in the oxygen market are Linde Group, Praxair Technology Inc., Air Liquide, Taiyo Nippon Sanso, Yingde Gases, Air Water Inc., Airgas Inc., Guangdong Haute Gas Co. Ltd., and Baosteel Metal Co. Ltd. Asia-Pacific was the largest region in the oxygen market in 2022. North America was the second-largest region in the global oxygen market. The regions covered in the global oxygen market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the oxygen market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The oxygen market consists of the sales of oxygen in cylinders, spray cans, and containers used as a catalyst. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global oxygen market is segmented - 1) By Product Type: Medical Oxygen, Industrial Oxygen, Other Product Types 2) By Application: Cosmetics, Pharmaceutical, Automobiles, Mining, Mineral processing applications 3) By End User Industry: Metallurgical Industry, Chemical Industry, Health Care Industry, Other End Use Industries

Oxygen concentrators are devices that separate nitrogen and oxygen from the air in the environment and provide pure oxygen to the patient. These are used for supplying oxygen to patients suffering from respiratory diseases. The main types of oxygen concentrators are portable and stationary. Portable oxygen concentrators are smaller, more mobile, affordable, and can be easily moved from one place to another. The different technologies include pulse dose, continuous flow, and others. These oxygen concentrators are used for supplying oxygen for patients suffering from chronic obstructive pulmonary disease (COPD), lung cancer, pneumonia, other respiratory system diseases and are used by hospitals, home care, others. The oxygen concentrators market research report is one of a series of new reports from The Business Research Company that provides oxygen concentrators market statistics, including oxygen concentrators industry global market size, regional shares, competitors with a oxygen concentrators market share, detailed oxygen concentrators market segments, market trends and opportunities, and any further data you may need to thrive in the oxygen concentrators industry. This oxygen concentrators market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global oxygen concentrators market size grew from $2.83 billion in 2022 to $3.01 billion in 2023 at a compound annual growth rate (CAGR) of 6.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The oxygen concentrators market size is expected to grow to $4.06 billion in 2027 at a CAGR of 7.8%. The increase in the prevalence of respiratory disorders across the globe contributes to the growth of the oxygen concentrators market. Globally, asthma and chronic obstructive pulmonary disease (COPD) are the most common chronic respiratory diseases. According to the Forum of International Respiratory Societies (FIRS), 384 million people suffer from COPD, and 3 million people die every year. Therefore, the increase in the prevalence of respiratory disorders is driving the growth of the oxygen concentrators market. Companies in the oxygen concentrators market are increasingly investing in technologies such as artificial intelligence and low-cost portable devices to improve the functionality of these oxygen concentrators. There has been a growing demand for portable, low-cost concentrators owing to the pandemic. For instance, in March 2021, a team of researchers at MIT’s Electrochemical Energy Lab (EEL) launched a low-cost portable concentrator that can be adopted in places with limited infrastructure and high demand. The companies such as Servotech Power Systems, an India-based manufacturer of LED lights and solar products is manufacturing the noiseless, lightweight, and portable oxygen concentrator equipment that provides a constant flow of oxygen and can be easily adjusted to meet the needs of the patient. In May 2021, OxyGo LLC, a manufacturer of portable oxygen concentrators, acquired LIFE Corporation for an undisclosed amount. Through this acquisition, OxyGo can offer services to compressed gas users, and the company can also expand its oxygen expertise by providing better products and services using LIFE corporation expertise. Life Corporation is an India-based company that manufactures portable emergency oxygen and CPR administration equipment. Major players in the oxygen concentrators market are Koninklijke Philips N.V., Invacare Corporation, DeVilbiss Healthcare LLC, Nidek Medical, Inogen, O2 Concepts, Teijin Limited, Supera Anesthesia Innovations, GCE Group, CAIRE Inc., Precision Medical Inc., ResMed, Linde, Longfian Scitech, and OxyGo. North America was the largest region in the oxygen concentrators market in 2022. Europe was the second-largest region in the oxygen concentrators market. The regions covered in the oxygen concentrators report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the oxygen concentrators market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The oxygen concentrators market consists of sales of Compressed gas systems, Portable oxygen concentrators (POCs), and Liquid oxygen systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global oxygen concentrators market is segmented - 1) By Type: Portable, Stationary 2) By Technology: Pulse Dose, Continuous Flow, Other Technologies 3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, Pneumonia, Other Applications 4) By End User: Hospitals, Home Care, Other End Users

Respiratory devices and equipment (therapeutic and diagnostic) are used to provide medication or assist a patient who is having difficulty in breathing and cannot achieve adequate oxygen levels to maintain life. Patients with respiratory disorders such as asthma, cystic fibrosis, chronic obstructive pulmonary disease, and acute respiratory distress syndrome require respiratory devices. The main types of respiratory devices and equipment are diagnostic devices, therapeutic devices, and monitoring devices. The diagnostic devices are used to diagnose respiratory-related issues. The various therapeutic devices are humidifiers, nebulizers, oxygen concentrators, positive airway pressure (PAP) devices, ventilators, and others. The diagnostic devices involved are spirometer, polysomnographs, and peak flow meters and monitoring devices are pulse oximeters, capnography, and gas analyzers. These provide applications in chronic obstructive pulmonary disease (COPD), asthma, obstructive sleep apnea (OSA), respiratory distress syndrome (RDS), cystic fibrosis, and pneumonia. These are used by hospitals, clinics, home care settings, and ambulatory service centres. The respiratory devices and equipment (therapeutic and diagnostic) market research report is one of a series of new reports from The Business Research Company that provides respiratory devices and equipment (therapeutic and diagnostic) market statistics, including respiratory devices and equipment (therapeutic and diagnostic) industry global market size, regional shares, competitors with a respiratory devices and equipment (therapeutic and diagnostic) market share, detailed respiratory devices and equipment (therapeutic and diagnostic) market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory devices and equipment (therapeutic and diagnostic) industry. This respiratory devices and equipment (therapeutic and diagnostic) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global respiratory devices and equipment (therapeutic and diagnostic) market size will grow from $29.09 billion in 2022 to $32.76 billion in 2023 at a compound annual growth rate (CAGR) of 12.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The respiratory devices and equipment (therapeutic and diagnostic) market size is expected to grow to $50.54 billion in 2027 at a CAGR of 11.5%. The global therapeutic respiratory devices and equipment market will be driven by the increase in diseases such as Chronic Obstructive Pulmonary Disease (COPD), asthma, and lung cancer. Growth in the geriatric population, tobacco consumption, allergens, and air pollutants increase the prevalence of respiratory diseases, in turn driving the global therapeutic respiratory devices market. According to World Health Organisation,4.9 million people die due to tobacco consumption, and smoking causes chronic obstructive pulmonary diseases (1 million deaths annually), cardiovascular and respiratory diseases (1.7 million deaths annually), and lung cancer (0.85 million deaths annually). According to an Italian journal, COPD in the U.S. is estimated to be 10% in the population aged 75 years or over. According to Asthma UK, 5.4 million people in the UK are currently receiving treatment for asthma out of these 1.1 million are children and 4.3 million are adults. A longer duration of time taken in the approval process of the respiratory devices is restricting the respiratory devices and equipment market growth. Before a new respiratory device is introduced to the market, it takes 7.2 months for the FDA approval process, which adds to development costs to be borne by device manufacturers, thus acting as a restraint hindering the market growth. For instance, FDA reviews about 4,000 submissions every year and takes about 3 to 6 months in clearing most of them. In addition to this, to reduce incidences associated with the respiratory devices and ensure that the devices are safe and have the least adverse reactions, the Medicines and Healthcare products Regulatory Agency (MRHA), UK regulates and monitors the devices by restricting devices for use and sending field safety notice to correct the devices. These stringent approval processes and regulatory policies may impact the respiratory devices and equipment market. Companies in the respiratory devices and equipment market are increasingly investing in enhanced mechanical ventilators for efficient patient management. These mechanical ventilators use artificial intelligence to improve patient management by examining, analyzing, integrating, and incorporating data from extensive sources. These AI-enabled devices ensure consistency even in the absence of expert personnel, improve patients' treatment, limit clinical mistakes, and predict prolonged mechanical ventilation by using artificial intelligence techniques. Some of the major companies offering intelligent mechanical ventilators such as Hamilton Medical AG, Koninklijke Philips N.V., and others. In June 2021, Philips respironics issued a voluntary recall notification after discovering potential health risks related to CPAP, BiPAP and Mechanical ventilator devices. The notification also included a field safety notice for users who did not intend to send the devices for repair. Major players in the respiratory devices and equipment market are Smiths Medical, Philips Healthcare, GE Healthcare, Chart Industries, Invacare Corporation, Fisher & Paykel Healthcare Limited, ResMed, Dragerwerk AG, Medtronic PLC., Masimo corp., and CareFusion Corporation. Asia-Pacific was the largest region in respiratory devices and equipment (therapeutic and diagnostic) market in 2022. Western Europe was the second-largest region in respiratory devices and equipment (therapeutic and diagnostic) market. The regions covered in respiratory devices and equipment (therapeutic and diagnostic) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the respiratory devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, USA, and Australia. The respiratory devices and equipment (therapeutic and diagnostic) market consists of sales of instruments such as humidifiers, nebulizers, oxygen concentrators, positive airway pressure (PAP) devices, ventilators, spirometer, polysomnographs, peak flow meters, pulse oximeters, capnographs, and gas analyzers. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global respiratory devices and equipment (therapeutic and diagnostic) market is segmented - 1) By Type: Diagnostic devices, Therapeutic devices, Monitoring devices 2)By End User: Hospitals, Clinics, Homecare settings, Ambulatory service centers, 3) By Therapeutic Devices: Humidifiers, Nebulizers, Oxygen concentrators, Positive Airway Pressure (PAP) Devices, Ventilators, Other Therapeutic Devices 4) By Diagnostic Devices: Spirometer, Polysomnographs, Peak Flow Meters 5) By Monitoring Devices: Pulse oximeters, Capnographs, Gas analyzers 6) By Application: Chronic Obstructive Pulmonary Disease (COPD), Asthma, Obstructive Sleep Apnea (OSA), Respiratory Distress Syndrome (RDS), Cystic Fibrosis, Pneumonia

The oxygen flow meter measures and regulates the amount of oxygen delivered to patients who are receiving oxygen therapy. It can not only accurately detect the flow of oxygen in real-time, but it can also keep healthcare providers informed about a patient's oxygen absorption status. Oxygen flowmeters are now routinely utilized in hospitals at all levels. The main types of oxygen flow meters are double flange type, plug-in type, and others. Plug-in type O2 flow meters are mostly used in the healthcare industry, such as in hospitals, surgical facilities, and clinics, to monitor or control high-pressured oxygen provided from an O2 cylinder. The different calibration types include automatic and manual and are used in healthcare, industrial, aerospace, chemical, and other applications. The oxygen flow meters market research report is one of a series of new reports from The Business Research Company that provides oxygen flow meters market statistics, including oxygen flow meters industry global market size, regional shares, competitors with a oxygen flow meters market share, detailed oxygen flow meters market segments, market trends and opportunities, and any further data you may need to thrive in the oxygen flow meters industry. This oxygen flow meters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global oxygen flow meters market size grew from $1.54 billion in 2022 to $1.68 billion in 2023 at a compound annual growth rate (CAGR) of 9.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The oxygen flow meters market size is expected to grow to $2.31 billion in 2027 at a CAGR of 8.2%. The increasing number of COVID-19 cases in the world is expected to propel the growth of the oxygen flowmeter market going forward. COVID-19 disease (COVID-19) is an infectious disease caused by the virus called SARS-CoV-2. The majority of those infected with the virus will experience mild to moderate respiratory symptoms and require external oxygen to breathe. For instance, according to the Worldometer, a US-based reference website that provides live world statistics, the total new COVID-19 cases found on 25th April 2022 is 510 million, has jumped to 511 million on 27th April 2022. Therefore, the increasing number of COVID-19 cases drives the oxygen flowmeter market. New product developments have emerged as a key trend gaining popularity in the oxygen flowmeters market. Major companies operating in the oxygen flowmeters sector are focused on new product innovations to meet consumer demand and strengthen their position. For instance, In August 2021, Guangzhou Aosong Electronics Company Ltd., a China-based manufacturer of temperature and humidity sensors, launched a new intelligent digital gas mass flow meter based on advanced semiconductor technology. This product features high sensitivity, a versatile output mode, and a wide range of stability. The AMS2106 uses thermal mass flow measurement without the need for additional temperature and pressure correction from the client, ensuring high-precision flowmeter calculations, high sensitivity, and the ability to quickly detect the minimum starting flow rate and begin the calculation. In January 2022, ICU Medical Inc., a US-based medical company, acquired Smiths Medical for an undisclosed amount. With this acquisition, ICU Medical Inc will continue providing innovation, quality, and value to clinical customers worldwide. Smiths Medical is a US-based company that provides oxygen flow meters. Major players in the oxygen flow meters market are D.Z. Medicale S.r.l., Heyer Medical AG, Ohio Medical Corporation, Megasan Medical, Precision Medical Inc., HERSILL, Penlon Ltd., BURAK Metering Pvt. Ltd., Amcaremed Technology Co. Limited, Dwyer Instruments Ltd., Burak Metering, Deluxe Industrial Gases, Sumukha Meditek, and Ashish Engineering. North America was the largest region in the oxygen flow meters market in 2022. The regions covered in the oxygen flow meters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the oxygen flow meters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The oxygen flow meter market consists of sales of thorpe tube oxygen flow meter, bourdon gauge oxygen flow meter, and dial/click oxygen flow meter. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global oxygen flow meters market is segmented - 1) By Type: Double Flange Type, Plug-in Type, Other Types 2) By Calibration Type: Automatic, Manual 3) By Application: Healthcare, Industrial, Aerospace, Chemical, Other Applications

Pharmaceutical drug refers to a substance created to treat, prevent, or cure an illness or other condition, or to lessen its symptoms. To list the most popular methods, drugs can be consumed orally, through a skin patch, by injection, or through an inhaler. Other vital medications made from natural materials include vaccinations, steroid hormones, human blood-plasma fractions, and antibiotics. The main types of pharmaceutical drugs are cardiovascular drugs, dermatology drugs, gastrointestinal drugs, genito-urinary drugs, hematology drugs, anti-infective drugs, metabolic disorders drugs, musculoskeletal disorders drugs, central nervous system drugs, oncology drugs, ophthalmology drugs, and respiratory diseases drugs. Cardiovascular drugs are used to treat medical conditions associated with the heart or the circulatory system (blood vessels), such as arrhythmias, blood clots, coronary artery disease, high or low blood pressure, high cholesterol, heart failure, and stroke. The drugs are administered through oral, parenteral, and others that are classified into branded and generic drugs. The various mode of purchase includes prescription-based drugs and over-the-counter drugs which are distributed by hospital pharmacies, retail pharmacies/ drug stores, and others. The pharmaceutical drug market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical drug market statistics, including pharmaceutical drug industry global market size, regional shares, competitors with a pharmaceutical drug market share, detailed pharmaceutical drug market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical drug industry. This pharmaceutical drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global pharmaceutical drugs market is expected to grow from $ 1,136.23 billion in 2022 to $1,199.86 billion in 2023 at a compound annual growth rate (CAGR) of 5.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, affecting many markets across the globe. The pharmaceutical drugs market is expected to reach $1,848.49 billion in 2027 at a CAGR of 11.4%. The rise in sedentary jobs, busy lifestyles, and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes, and cardiovascular diseases. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of chronic diseases such as diabetes. According to the World Health Organization, chronic disease prevalence rose by 57% globally, in the year 2020. China and India together had about 193.4 million diabetic patients in 2019 and India is expected to have about 101 million diabetic patients by 2030, thereby increasing the need for biologics drugs for diabetic patients. These factors are expected to increase the patient pool globally, thereby driving the pharmaceutical drug market during the forecast period. Interest rates globally are forecasted to rise in most of the developing and developed economies, during the forecast period, this is expected to limit new investments in the market. Most countries across the world are raising interest rates to control inflation and also to limit the flow of capital out of the country. This is likely to affect new investments in terms of expansion, research, and development of new products. For instance, the US interest rates rose to 3.5% by 2021. These factors are expected to hurt the market as borrowing money becomes expensive, thereby affecting the pharmaceuticals market growth. Early Rx-to-OTC switch, or switching the product from prescription to non-prescription status, is a key trend in the dermatology drugs market. Traditionally, the Rx-to-OTC status conversion was generally observed at a phase nearing the patent expiry or after. However, forward-thinking companies are now looking at switching from Rx-to-OTC well in advance of the patent expiry of the drug. This helps the manufacturer to capitalize on the market opportunities for the product. Early Rx-to-OTC switching also provides an additional benefit as a way to recover all the expenses incurred on the product by the company. For example, in 2020, FDA has switched three prescription drugs to OTC including Voltaren for arthritis pain, olopatadine hydrochloride 0.1% and 0.2% (Pataday Twice Daily Relief and Pataday Once Daily Relief) for temporary relief of itchy and red eyes due to pollen, ragweed, and grass. Major companies in the pharmaceutical drugs market include Bristol-Myers Squibb, Sanofi S.A, Johnson & Johnson, Novartis AG, Bayer AG, Abbott Laboratories, GlaxosmithKline, AstraZenec, Merck & Co and CJ Corp. North America was the largest region in the pharmaceutical drugs market in 2022. Middle East is expected to be the fargest growing region in the forecast period. The regions covered in the pharmaceutical drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the pharmaceutical drugs market report are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela and Vietnam. The pharmaceutical drug market consists of sales of generic drugs, over-the-counter medications, bulk drugs, vaccines, biosimilars, and biologics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global pharmaceutical drugs market is segmented - 1) By Type: Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorders Drugs, Musculoskeletal Disorders Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Diseases Drugs 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Other Distribution Channels 3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration 4) By Drug Classification: Branded Drugs, Generic Drugs 5) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs Subsegments Covered: Anti-Hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs), Acne Drugs, Dermatitis, Psoriasis, Other Drugs for Dermatology Diseases, Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrhoeals, Hormonal Contraceptives, Drugs For Benign Prostatic hypertrophy, Drugs For Infertility, Drugs For Erectile Dysfunction, Drugs For Urinary Incontinence And Overactive Bladder, Drugs For Infections And Others, Drugs For Hormonal Replacement Therapy, Diuretics, Blood Products, Anemia And Other Blood Disorder Drugs, Antibiotics, Antivirals, Antifungals, Others (Anthelminthic, Antiprotozoal), Anti Diabetics drugs, Anti-Thyroid Drugs, Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism), Drugs For Rheumatoid Arthritis, Muscle Relaxants, Other Musculoskeletal Disorders Drugs, Analgesics, Anti-Parkinson drugs, Anesthetics, Anti-Epileptics, Other CNS drugs, Lung Cancer Drugs, Pancreatic Cancer Drugs, Breast Cancer Drugs, Prostate Cancer Drugs, Ovarian Cancer Drugs, Colorectal Cancer Drugs, Gastric Cancer Drugs, Kidney Cancer Drugs, Brain Tumor Drugs, Thyroid Cancer Drugs, Skin Cancer Drugs, Bladder Cancer Drugs, Cervical Cancer Drugs, Blood Cancer Drugs, Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma), Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy), Anti-Asthmatics And COPD Drugs, Cough And Cold Preparations

Bi-specific MAbs or bispecific monoclonal antibodies refer to antibodies that have two binding sites and are designed to bind to two antigens that are either distinct or have two different epitopes. Monoclonal antibodies (MoAbs) do not have the clinical therapeutic effects of BsAbs, which have a wide range of applications for the treatment of different diseases as well as tumour immunotherapy. The main types of bi-specific are catumaxomab (removal), blinatumomab, duligotumab, and SAR 156597. Catumaxomab is a rat-mouse hybrid monoclonal antibody used to treat malignant ascites, a condition that occurs in people who have metastasizing cancer. The various product types including in vivo, and in vitro are used for the treatment of cancer, autoimmune diseases, inflammatory diseases, infectious diseases, microbial diseases, and others. The bispecific monoclonal antibodies are used by hospitals, research institutes, and others. The bi-specific MAbs or bispecific monoclonal antibodies market research report is one of a series of new reports from The Business Research Company that provides bi-specific MAbs or bispecific monoclonal antibodies market statistics, including bi-specific MAbs or bispecific monoclonal antibodies industry global market size, regional shares, competitors with a bi-specific MAbs or bispecific monoclonal antibodies market share, detailed bi-specific MAbs or bispecific monoclonal antibodies market segments, market trends and opportunities, and any further data you may need to thrive in the bi-specific MAbs or bispecific monoclonal antibodies industry. This bi-specific MAbs or bispecific monoclonal antibodies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global bi-specific mabs market grew from $5.13 billion in 2022 to $6.72 billion in 2023 at a compound annual growth rate (CAGR) of 31.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The bi-specific mabs market is expected to grow from $13.16 billion in 2027 at a CAGR of 18.3%. The increasing prevalence of cancer and other chronic diseases is projected to contribute to the growth of the bispecific monoclonal antibodies market over the forecast period. Bispecific monoclonal antibodies are developed for the treatment of various cancers, infectious diseases, central nervous system disorders, and autoimmune disorders. Bispecific monoclonal antibodies are considered to be more effective than monoclonal antibodies (moAbs) as these target two or more tumor antigens on cells to disrupt cancer progression. For instance, in February 2022, according to the World Health Organization, a Switzerland-based international public health agency of the United Nations, cancer will be the leading cause of deaths across the globe, causing almost 10 million fatalities in 2020, or almost one in every six deaths. Breast, lung, colon, rectum, and prostate cancers are the most prevalent types of cancer. Additionally, in October 2022, according to the Centers for Disease Control and Prevention, chronic diseases will be among the most prevalent diseases, with 6 out of 10 adults suffering from at least one chronic disease in the USA. Therefore, a rising number of chronic diseases, including cancer, is anticipated to propel the demand for bi-specific MAbs to treat these diseases effectively. The availability of various alternative treatment methods for cancer is expected to limit the growth of the bispecific monoclonal antibodies market. Alternative cancer treatment therapies and methods used for the treatment of cancer including dietary treatments, acupuncture, homeopathy, and herbal remedies are gaining popularity in recent years attributed to side effects of chemotherapeutic anticancer agents. For instance, Ayurvedic medicine, an ancient Indian system of medicine uses a range of techniques and treatments for cancer. Many of the herbs used in Ayurveda have anti-cancer properties, for example, andrographispaniculata. According to the World Health Organization (WHO), some nations are still responding to plant-based treatment as their main medicine source, and developing nations are using the benefits of natural compounds for therapeutic purposes. Therefore, this affects the biologic sales and hence impacts the bi-specific MAbS market. Also, the global homeopathic product market is projected to reach $18.6 billion by the end of 2027, growing at a CAGR of 14% during the forecast period. The less expensive alternative medicines increase competition for the biologics market, thereby, hindering the growth of the bi-specific MAbs market shortly. Companies in the bi-specific MAbS market are increasingly investing in various strategic initiatives such as collaborations and partnerships to expand the product portfolio and geographical presence of the company. For instance, in June 2020, AbbVie Inc., a US-based biopharmaceutical company entered into a collaboration agreement with Genmab A/S, a Danish biotechnology company, to develop and commercialize antibody therapeutics for cancer treatment. The companies together will work on three early-stage bispecific antibody candidates of Genmab A/S including DuoHexaBody-CD37, epcoritamab, and DuoBody-CD3x5T4 along with discovering new antibody therapeutics. Moreover, in July 2020, Atreca, Inc., a US-based clinical-stage biotechnology company, and Xencor, Inc. entered into a strategic partnership to develop, discover, and commercialize Novel T cell engaging bispecific antibodies as potential therapeutics for oncology treatment. Xencor, Inc. is a US-based biopharmaceutical company developing engineered monoclonal antibodies for cancer and autoimmune disease treatment. In August 2020, AbCellera, a biotechnology firm based in Canada, completed the acquisition of the OrthoMab bispecific platform from Dualogics for an undisclosed amount. The acquisition integrated OrthoMab into AbCellera’s existing technology stack, which provided the industry with a rapid and complete solution for generating tailored, stable, and developable bispecific antibodies Dualogics is a US-based biotechnology company specialized in protein engineering for improving antibody therapeutics. Major players in the bi-specific MAbs or bispecific monoclonal antibodies market are Johnson & Johnson, Novartis AG, Hoffmann-La Roche Ltd., Novo Nordisk A/S, Bayer AG, Thermo Fisher Scientific, Inc., Bistro-Myers Squibb. Mylan N.V., Daiichi Sankyo Company Ltd. and Abbott. North America was the largest region in the bi-specific MAbS market in 2022. The regions covered in the global bi-specific MAbs or bispecific monoclonal antibodies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the global bi-specific MAbs or bispecific monoclonal antibodies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The bi-specific MAbs or bispecific monoclonal antibodies market consists of sales of trifunctional antibodies, chemically linked Fabs, and bispecific T cell engagers. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global BI-specific MAbS market is segmented - 1)By Type: Catumaxomab (Removab), Blinatumomab, Duligotumab, SAR 156597 2)By Product Type: In Vivo, In Vitro 3)By Indication: Cancer, Autoimmune Diseases, Inflammatory Diseases, Infectious Diseases, Microbial Diseases, Other Indications 4)By End Use: Hospitals, Research Institutes, Other End-Users

The industrial gas regulator refers to devices used to regulate the pressure and direction of fluid or gas in the piping in various industries. An industrial gas regulator consists of a separate pressure sensor, a controller, a flow valve, and a diaphragm that regulates the pressure when gas enters the chamber, and the fuel can then be delivered from the source to the appliance or device at a certain flow. The main types of industrial gas regulators are single-stage and dual-stage. The single-stage is used to produce high-purity single-stage gas pressure regulators that are made to regulate the delivery pressures of gases that are either derived from high-pressure bottles or are provided by a facility's line pressure. The various gases include inert, corrosive, and toxic ones. The materials include brass and stainless steel. These are used in oil and gas, chemicals, steel and metal processing, medical care, food and beverages, and other applications. The industrial gas regulators market research report is one of a series of new reports from The Business Research Company that provides industrial gas regulators market statistics, including global and regional shares, competitors with an industrial gas regulators market share, detailed industrial gas regulators market segments, market trends, and opportunities, and any further data you may need to thrive in the industrial gas regulators industry. This industrial gas regulators market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global industrial gas regulators market size grew from $15.49 billion in 2022 to $16.47 billion in 2023 at a compound annual growth rate (CAGR) of 6.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, causing inflation across goods and services and affecting many markets across the globe. The industrial gas regulators market size is expected to grow to $20.76 billion in 2027 at a CAGR of 6.0%. Rapid industrialization is expected to propel the growth of the industrial gas regulator market going forward. Industrialization refers to an economy's transformation from one focused mostly on agriculture to one based on the production of goods. Industrialization has transformed the economy with the production of a variety of goods in various industries, and industrial gas regulators are one of them. For instance, in March 2022, according to the United Nations Industrial Development Organization, an Austria-based specialised agency, global manufacturing production increased by 9.4 % in 2021, after the pandemic-related drop of 4.2 percent in 2020. Further, by March 2022, according to the India Brand Equity Foundation (IBEF), an India-based government export promotion agency, Indian manufacturing hubs will reach more than $500 billion by 2030. Many companies have started producing their products in India, such as the first solar company started a plant in Tamil Nadu. Zoho invested $13.4 million in R&D manufacturing. Therefore, rapid industrialization is driving the industrial gas regulator market. Technological advancement is a key trend gaining popularity in the industrial gas regulator market. Major companies in the industrial gas regulator market are developing new technologies to strengthen their position. For instance, in April 2021, The Cavagna Group, a UK-based company operating in industrial gas regulators, launched the Viproxy i-1Touch, a brand new digital valve for medical oxygen therapy with a smart IoT add-on and a unique, smart medical VPR that has data transmission capabilities. The Viproxy i-1Touch valve includes an integrated pressure regulator as well as a digital pressure gauge.Its digital gauge will clearly display all parameters monitored during use and send audible alerts. In February 2022, Control Devices LLC, a US-based producer of premium valves and industrial parts acquire Essex Industries' medical gas regulator business for an undisclosed amount. This acquisition expanded Control Devices' offering in the area of medical gas regulators. The Control Devices brand will now be used to sell the Essex Industries medical gas regulator product range. EssexIndustries, Inc. is a US-based company operating in the industrial gas regulator market. Emerson Electric Co., Linde PLC., Air Liquide S.A, Praxair Inc., Air Products and Chemicals Inc., GCE Group, Itron Cavagna Group Spa, Iwatani Corporation, Messer Group GmbH, Matheson Tri-Gas Inc., Iceblick Ltd., Advanced Specialty Gases, BASF SE, Buzwair Group, Ellenbarrie Industrial Gases Ltd., Gulf Cryo, and Proton Gases Private Limited are the major playersd North America was the largest region in the industrial gas regulator market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this industrial gas regulator market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the industrial gas regulator market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The industrial gas regulator market consists of sales of regulator including brass and stainless-steel gas regulators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global industrial gas regulators market is segmented - 1) By Type: Single Stage, Dual Stage 2) By Gas: Inert, Corrosive, Toxic 3) By Material: Brass, Stainless Steel 4) By Application: Oil and Gas, Chemical, Steel and Metal Processing, Medical Care, Food and Beverages, Other Applications

Paper is a thin, flexible material that is typically manufactured in sheets from rags, wood, and lastics are a collection of materials, either man-made or natural, that can be molded while still soft and then hardened to keep the desired shape; rubber is a material that can be made stretchy by coagulating the milky juice of a variety of tropical plants; wood refers to the majority of the stems, branches, and roots of trees and shrubs are made of a hard fibrous substance called xylem that lies beneath the bark, and "textile" is a colloquial term for any fabric or product made by knitting, felting, or weaving. The main types of paper, plastics, rubber, wood and textile are apparel and leather products, furniture, general manufactured goods, paper products, plastics and rubber products, printing and related support activities, textile and wood products. Leather and allied product manufacturers turn hides into leather by tanning or curing them and then constructing them into finished products, as well as producing similar goods from other materials, such as leather alternatives like rubber, polymers, or textiles (excluding clothes). The different natures include organic, conventional and is distributed through various channels such as supermarkets or hypermarkets, convenience stores, e-commerce, others. The paper, plastics, rubber, wood and textile market research report is one of a series of new reports from The Business Research Company that provides paper, plastics, rubber, wood and textile market statistics, including paper, plastics, rubber, wood and textile industry global market size, regional shares, competitors with a paper, plastics, rubber, wood and textile market share, detailed paper, plastics, rubber, wood and textile market segments, market trends and opportunities, and any further data you may need to thrive in the paper, plastics, rubber, wood and textile industry. This paper, plastics, rubber, wood and textile market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global paper, plastics, rubber, wood and textile market grew from $6573.88 billion in 2022 to $7032.76 billion in 2023 at a compound annual growth rate (CAGR) of 7.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The paper, plastics, rubber, wood and textile market is expected to grow to $8939.16 billion in 2027 at a CAGR of 6.2%. Rapid Technological Development - Technology is expected to be a continued driver of market growth during this period. Industries that involve technology, such as this one, benefited from this trend during this period. For example, technologies such as "Green Tires," where 20-30% of a vehicle's fuel consumption is related to tire performance, took off during this period. Green Tires offer wet grip, durability and low rolling resistance, reducing fuel consumption by 5-7%. Thus, technological advances which enabled improved performance, reduced fuel consumption contributed to the market growth. Corona virus Pandemic - The outbreak of Corona virus disease (COVID-19) has acted as a massive restraint on the paper, plastics, rubber, wood and textile manufacturing market in 2022 as supply chains were disrupted due to trade restrictions and consumption declined due to lockdowns imposed by governments globally. COVID-19 is an infectious disease with flu-like symptoms including fever, cough, and difficulty in breathing. The virus was first identified in 2019 in Wuhan, Hubei province of the People's Republic of China and spread globally including Western Europe, North America and Asia. Steps by national governments to contain the transmission have resulted in halting of manufacturing activities and a decline in economic activity with countries entering a state of 'lock down' and the outbreak had a negative impact on businesses throughout 2021 and into 2021. However, it is expected that the paper, plastics, rubber, wood and textile manufacturing market will recover from the shock across the forecast period as it is a 'black swan' event and not related to ongoing or fundamental weaknesses in the market or the global economy. Manufacturers in the plastic products industry are investing in automation technologies to reduce production costs, improve productivity and enhance product quality. The use of sensors and wireless technology aids in gathering valuable data that is used to improve efficiencies and reduce errors. This is resulting in streamlined manufacturing processes, better product quality at lower costs. According to ABB, an industrial robot manufacturer, some of their customers reported an increase of 15-30% in productivity after installing robotic automation systems. Around 180,000 machines were employed in the plastic manufacturing industry in 2021, an increase of 67,000 machines over the course of 4 years. Major companies providing industrial robotics include FANUC Corporation, Yaskawa Electric Corporation, ABB Group, KUKA AG, and Kawasaki Heavy Industries, Ltd. Major companies in the paper, plastics, rubber, wood and textile market include Nike Inc., Christian Dior SE, The Michelin Group, Adidas AG, Bridgestone Corporation, International Paper Company, Kimberly Clark Corporation, Rajesh Exports, Procter & Gamble and WestRock Company. Asia-Pacific was the largest region in the paper, plastics, rubber, wood and textile market in 2022. Western Europe was the second largest region in the paper, plastics, rubber, wood and textile market. The regions covered in the paper, plastics, rubber, wood and textile market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the paper, plastics, rubber, wood and textile market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam. The paper, plastic, rubber, wood, and textile market consists of sales of clothes, groceries, and wood furniture. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global paper, plastics, rubber, wood and textile market is segmented - 1) By Type: Apparel And Leather Products, Furniture, General Manufactured Goods, Paper Products, Plastics And Rubber Products, Printing And Related Support Activities, Textile, Wood Products 2) By Distribution Channel: Supermarkets/Hypermarkets, Convenience Stores, E-Commerce, Other Distribution Channels 3) By Nature: Organic, Conventional Subsegments Covered: Leather And Allied Products, Apparel, Institutional And Office Furniture, Household Furniture And Kitchen Cabinet, Mattresses, Blinds And Shades, Jewelry And Silverware, Sporting And Athletic Goods, Doll, Toy, And Game, Office Supplies (except Paper), Sign, All Other Miscellaneous Manufactured Goods, Converted Paper Products, Unfinished Paper, Pulp Mills, Rubber Products, Plastic Products, Printing, Support Activities For Printing, Other Textile Product Mills, Fabrics, Yarn, Fiber And Thread, Home Furnishings And Floor Coverings, Textile and Fabric Finishing and Fabric Coating Mills, Finished Wood Products, Wood Processing, Manufactured Wood Materials